Bioequivalence Study Comparing 2 Formulations of LY900014 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 16 Nov 2018
Price : $35 *
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
- 05 Nov 2018 Status changed from active, no longer recruiting to completed.
- 22 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 11 Sep 2018 Planned End Date changed from 1 Oct 2018 to 19 Oct 2018.